[F:1][C:2]([F:20])([F:19])[CH:3]([NH:11][C:12](=O)OC(C)(C)C)[C:4]([N:6]1[CH2:9][CH:8]([OH:10])[CH2:7]1)=O.[H-].[H-].[H-].[H-].[Li+].[Al+3].C1COCC1.CCOC(C)=O>C(Cl)Cl.O.C1COCC1>[F:20][C:2]([F:1])([F:19])[CH:3]([NH:11][CH3:12])[CH2:4][N:6]1[CH2:7][CH:8]([OH:10])[CH2:9]1Tert-butyl 1,1,1-trifluoro-3-(3-hydroxyazetidin-1-yl)-3-oxopropan-2-ylcarbamate (Compound B3.1) (3.97 gg, 13.3 mmol) was added under argon in portions to 1M solution of LAH in THF (53 mL, 53 mmol) over 15 min. The mixture was heated under argon to reflux for 7 h. After additional standing for 15 h at rt EtOAc (10 mL) was added dropwise under ice cooling, followed by addition of water/THF (1:1, 12 mL). The mixture was diluted with DCM (120 mL). Celite was added and the suspension was stirred for 10 min. The mixture was filtered, the solids washed with DCM (2×50 mL). The combined filtrates were dried (Na2SO4) and concentrated under reduced pressure to give the title compound (2.39 g, 91%). The obtained crude product was used in the next step without characterization.